Surface scattering characteristics and the measurement of particulate contamination

Surface scattering measurement techniques can be adopted for use in spacecraft contamination control programs. A witness mirror measurement program was developed and implemented for the NASA Cosmic Background Explorer (COBE) spacecraft. Scattering measurements were obtained before and after a qualification level vibration test for several COBE prototype instruments. The measurements indicate that a significant amount of particle redistribution occurred during the vibration test. The methodology used and the results obtained from this monitoring program are discussed

End-to-End System Test and Optical Performance Evaluation for the Solar and Heliosphere Observatory (SOHO) Ultraviolet Coronagraph Spectrometer (UVCS)

The UVCS is one of the instruments carried by the Solar and Heliospheric Observatory (SOHO), a joint NASA/ESA Spacecraft launched in November 1995. It is designed to perform ultraviolet spectroscopy and visible light polarimetry of the extended solar corona. The primary scientific objectives of the UVCS investigation are to study the physical processes occurring in the extended solar corona, such as: the mechanism of acceleration of the solar wind, the mechanism of coronal plasma heating, the identification of solar wind sources, and the investigation of the plasma properties of the solar wind. The UVCS End-to-End test activities included a comprehensive set of system level functional and optical tests. Although performed under severe schedule constraints, the End-to-End System Test was very successful and served to fully validate the UVCS optical design. All test results showed that the primary scientific objectives of the UVCS Mission were achievable

Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)